These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6870769)

  • 1. [Metabolic radical formation from halothane and enflurane and their modification by enzyme induction and inhibition].
    Beuter W; Schmid A
    Berl Munch Tierarztl Wochenschr; 1983 May; 96(5):171-3. PubMed ID: 6870769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic radical formation from tetrachloroethylene and its modification by enzyme induction or inhibition].
    Schmid A; Beuter W
    Zentralbl Veterinarmed A; 1982 Sep; 29(7):481-8. PubMed ID: 6815923
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of thyroid dysfunction on the metabolism of halothane, enflurane and methoxyflurane in rats.
    Siegers CP; Mackenroth T; Wächter S; Younes M
    Pharmacology; 1981; 22(1):41-6. PubMed ID: 7220596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free radical formation in vivo and hepatotoxicity due to anesthesia with halothane.
    Plummer JL; Beckwith AL; Bastin FN; Adams JF; Cousins MJ; Hall P
    Anesthesiology; 1982 Sep; 57(3):160-6. PubMed ID: 6287886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biotransformation of halogen anesthetics and liver toxicity].
    Duvaldestin P; Desmonts JM
    Ann Anesthesiol Fr; 1976; 17(3):315-20. PubMed ID: 984518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current knowledge on pharmacokinetics of halothane and enflurane.
    Lazarus G; Rietbrock I
    Acta Anaesthesiol Belg; 1980; 31(3):185-93. PubMed ID: 7457050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrahepatic biotransformation of halothane and enflurane.
    Blitt CD; Gandolfi AJ; Soltis JJ; Brown BR
    Anesth Analg; 1981 Mar; 60(3):129-32. PubMed ID: 7193988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of piperonyl butoxide on halothane hepatotoxicity and metabolism in the hyperthyroid rat.
    Smith AC; Roberts SM; Berman LM; Harbison RD; James RC
    Toxicology; 1988 Jun; 50(1):95-105. PubMed ID: 3388433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective metabolism of halothane enantiomers to trifluoroacetylated liver proteins.
    Martin JL; Meinwald J; Radford P; Liu Z; Graf ML; Pohl LR
    Drug Metab Rev; 1995; 27(1-2):179-89. PubMed ID: 7641575
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study of conjugates of a catabolite common to halothane, enflurane and fluroxene in guinea pigs].
    Mathieu A; Di Padua D
    Ann Anesthesiol Fr; 1976; 17(3):311-4. PubMed ID: 10782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbic acid inhibition of cytochrome P450-catalyzed uroporphyrin accumulation.
    Sinclair PR; Gorman N; Walton HS; Bement WJ; Jacobs JM; Sinclair JF
    Arch Biochem Biophys; 1993 Aug; 304(2):464-70. PubMed ID: 8346921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo spin-trap study on anaerobic dehalogenation of halothane.
    Fujii K; Morio M; Kikuchi H; Ishihara S; Okida M; Ficor F
    Life Sci; 1984 Jul; 35(5):463-8. PubMed ID: 6087064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of anesthetic agents: toxic implications.
    Van Dyke RA
    Acta Anaesthesiol Scand Suppl; 1982; 75():7-9. PubMed ID: 6958162
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of concentrations of halothane and enflurane to their metabolism and elimination in man.
    Cahalan MK; Johnson BH; Edger EI
    Anesthesiology; 1981 Jan; 54(1):3-8. PubMed ID: 7457979
    [No Abstract]   [Full Text] [Related]  

  • 15. Does evidence of reductive halothane biotransformation correlate with hepatic binding of metabolites in obese patients?
    Bentley JB; Vaughan RW; Cork RC; Gandolfi AJ
    Anesth Analg; 1981 Aug; 60(8):548-51. PubMed ID: 7196167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in blood concentrations of halothane and enflurane in the elimination phase (author's transl)].
    Reinhold P; Audick W; Bohn G
    Z Rechtsmed; 1981; 87(1-2):75-84. PubMed ID: 7303948
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotransformation of halothane and enflurane in patients with hyperthyroidism.
    Servin FF; Nivoche Y; Desmonts JM; Rice SA; Mazze RI
    Anesthesiology; 1986 Mar; 64(3):387-91. PubMed ID: 3754100
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and biotransformation alterations in obesity.
    Vaughan RW
    Contemp Anesth Pract; 1982; 5():55-70. PubMed ID: 7053318
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse.
    Boyd MR; Dutcher JS
    J Pharmacol Exp Ther; 1981 Mar; 216(3):640-6. PubMed ID: 7205642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and toxicologic studies with enflurane in Swiss/ICR mice.
    Baden JM; Rice SA; Wharton RS; Laughlin NK
    J Environ Pathol Toxicol; 1980 Aug; 4(1):293-303. PubMed ID: 7441115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.